These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34864488)

  • 1. A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination.
    Hu Z; Chen JP; Xu JC; Chen ZY; Qu R; Zhang L; Yao W; Wu J; Yang H; Lowrie DB; Liu Y; Fan XY
    Virology; 2022 Jan; 566():56-59. PubMed ID: 34864488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen.
    Wang Y; Wang L; Cao H; Liu C
    J Med Virol; 2021 Feb; 93(2):892-898. PubMed ID: 32691875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.
    Ober Shepherd BL; Scott PT; Hutter JN; Lee C; McCauley MD; Guzman I; Bryant C; McGuire S; Kennedy J; Chen WH; Hajduczki A; Mdluli T; Valencia-Ruiz A; Amare MF; Matyas GR; Rao M; Rolland M; Mascola JR; De Rosa SC; McElrath MJ; Montefiori DC; Serebryannyy L; McDermott AB; Peel SA; Collins ND; Joyce MG; Robb ML; Michael NL; Vasan S; Modjarrad K;
    Lancet Microbe; 2024 Jun; 5(6):e581-e593. PubMed ID: 38761816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.
    Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen.
    Srivastava V; Niu L; Phadke KS; Bellaire BH; Cho MW
    Front Immunol; 2021; 12():637982. PubMed ID: 33777030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen.
    Ramos-Duarte VA; Orlowski A; Jaquenod de Giusti C; Corigliano MG; Legarralde A; Mendoza-Morales LF; Atela A; Sánchez MA; Sander VA; Angel SO; Clemente M
    Vaccine; 2024 May; 42(14):3355-3364. PubMed ID: 38631949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2.
    Maxwell JWC; Stockdale S; Stewart EL; Ashley CL; Smith LJ; Steain M; Triccas JA; Byrne SN; Britton WJ; Ashhurst AS; Payne RJ
    ACS Infect Dis; 2024 Sep; 10(9):3419-3429. PubMed ID: 39196071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.
    Pillet S; Arunachalam PS; Andreani G; Golden N; Fontenot J; Aye PP; Röltgen K; Lehmicke G; Gobeil P; Dubé C; Trépanier S; Charland N; D'Aoust MA; Russell-Lodrigue K; Monjure C; Blair RV; Boyd SD; Bohm RP; Rappaport J; Villinger F; Landry N; Pulendran B; Ward BJ
    Cell Mol Immunol; 2022 Feb; 19(2):222-233. PubMed ID: 34983950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
    Richmond P; Hatchuel L; Dong M; Ma B; Hu B; Smolenov I; Li P; Liang P; Han HH; Liang J; Clemens R
    Lancet; 2021 Feb; 397(10275):682-694. PubMed ID: 33524311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice.
    Wørzner K; Sheward DJ; Schmidt ST; Hanke L; Zimmermann J; McInerney G; Karlsson Hedestam GB; Murrell B; Christensen D; Pedersen GK
    EBioMedicine; 2021 Jan; 63():103197. PubMed ID: 33422991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization.
    Haun BK; Lai CY; Williams CA; Wong TAS; Lieberman MM; Pessaint L; Andersen H; Lehrer AT
    Front Immunol; 2020; 11():599587. PubMed ID: 33193454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice.
    Yang H; Xie Y; Li S; Bao C; Wang J; Li C; Nie J; Quan Y
    Hum Vaccin Immunother; 2024 Dec; 20(1):2364519. PubMed ID: 38880868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
    Arunachalam PS; Walls AC; Golden N; Atyeo C; Fischinger S; Li C; Aye P; Navarro MJ; Lai L; Edara VV; Röltgen K; Rogers K; Shirreff L; Ferrell DE; Wrenn S; Pettie D; Kraft JC; Miranda MC; Kepl E; Sydeman C; Brunette N; Murphy M; Fiala B; Carter L; White AG; Trisal M; Hsieh CL; Russell-Lodrigue K; Monjure C; Dufour J; Spencer S; Doyle-Meyers L; Bohm RP; Maness NJ; Roy C; Plante JA; Plante KS; Zhu A; Gorman MJ; Shin S; Shen X; Fontenot J; Gupta S; O'Hagan DT; Van Der Most R; Rappuoli R; Coffman RL; Novack D; McLellan JS; Subramaniam S; Montefiori D; Boyd SD; Flynn JL; Alter G; Villinger F; Kleanthous H; Rappaport J; Suthar MS; King NP; Veesler D; Pulendran B
    Nature; 2021 Jun; 594(7862):253-258. PubMed ID: 33873199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2.
    Steinbuck MP; Seenappa LM; Jakubowski A; McNeil LK; Haqq CM; DeMuth PC
    Sci Adv; 2021 Feb; 7(6):. PubMed ID: 33547083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant.
    Ji J; Tang T; Zhu M; Wu Z; Zhang J; Shi D; Zhu L; Zhang X; Lu X; Chen L; Yao H
    Antiviral Res; 2024 Sep; 229():105954. PubMed ID: 38964615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.
    Goepfert PA; Fu B; Chabanon AL; Bonaparte MI; Davis MG; Essink BJ; Frank I; Haney O; Janosczyk H; Keefer MC; Koutsoukos M; Kimmel MA; Masotti R; Savarino SJ; Schuerman L; Schwartz H; Sher LD; Smith J; Tavares-Da-Silva F; Gurunathan S; DiazGranados CA; de Bruyn G
    Lancet Infect Dis; 2021 Sep; 21(9):1257-1270. PubMed ID: 33887209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.
    Didierlaurent AM; Collignon C; Bourguignon P; Wouters S; Fierens K; Fochesato M; Dendouga N; Langlet C; Malissen B; Lambrecht BN; Garçon N; Van Mechelen M; Morel S
    J Immunol; 2014 Aug; 193(4):1920-30. PubMed ID: 25024381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity.
    Zou GQ; Li K; Yan C; Li YQ; Xian MY; Hu X; Luo R; Liu Z
    Vaccine; 2024 Aug; 42(21):126145. PubMed ID: 39034218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
    Keech C; Albert G; Cho I; Robertson A; Reed P; Neal S; Plested JS; Zhu M; Cloney-Clark S; Zhou H; Smith G; Patel N; Frieman MB; Haupt RE; Logue J; McGrath M; Weston S; Piedra PA; Desai C; Callahan K; Lewis M; Price-Abbott P; Formica N; Shinde V; Fries L; Lickliter JD; Griffin P; Wilkinson B; Glenn GM
    N Engl J Med; 2020 Dec; 383(24):2320-2332. PubMed ID: 32877576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.